Highlights

[PHARMA] YoY Annualized Quarter Result on 2012-12-31 [#4]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 18-Feb-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2012
Quarter 31-Dec-2012  [#4]
Profit Trend QoQ -     -33.55%    YoY -     18.32%
Quarter Report


View:


Show?  YoY % Horiz. %

Annualized Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 2,189,312 2,122,933 1,946,639 1,812,346 1,520,981 1,378,348 1,300,796 9.06%
  YoY % 3.13% 9.06% 7.41% 19.16% 10.35% 5.96% -
  Horiz. % 168.31% 163.20% 149.65% 139.33% 116.93% 105.96% 100.00%
PBT 112,722 125,580 92,997 103,313 73,186 45,462 81,436 5.57%
  YoY % -10.24% 35.04% -9.99% 41.16% 60.98% -44.17% -
  Horiz. % 138.42% 154.21% 114.20% 126.86% 89.87% 55.83% 100.00%
Tax -28,138 -31,355 -36,236 -40,108 -20,401 -15,152 -19,709 6.11%
  YoY % 10.26% 13.47% 9.65% -96.60% -34.64% 23.12% -
  Horiz. % 142.77% 159.09% 183.86% 203.50% 103.51% 76.88% 100.00%
NP 84,584 94,225 56,761 63,205 52,785 30,310 61,727 5.39%
  YoY % -10.23% 66.00% -10.20% 19.74% 74.15% -50.90% -
  Horiz. % 137.03% 152.65% 91.95% 102.39% 85.51% 49.10% 100.00%
NP to SH 84,044 93,844 55,200 61,710 52,157 30,384 60,191 5.72%
  YoY % -10.44% 70.01% -10.55% 18.32% 71.66% -49.52% -
  Horiz. % 139.63% 155.91% 91.71% 102.52% 86.65% 50.48% 100.00%
Tax Rate 24.96 % 24.97 % 38.96 % 38.82 % 27.88 % 33.33 % 24.20 % 0.52%
  YoY % -0.04% -35.91% 0.36% 39.24% -16.35% 37.73% -
  Horiz. % 103.14% 103.18% 160.99% 160.41% 115.21% 137.73% 100.00%
Total Cost 2,104,728 2,028,708 1,889,878 1,749,141 1,468,196 1,348,038 1,239,069 9.23%
  YoY % 3.75% 7.35% 8.05% 19.14% 8.91% 8.79% -
  Horiz. % 169.86% 163.73% 152.52% 141.17% 118.49% 108.79% 100.00%
Net Worth 529,482 525,526 486,754 471,886 514,273 421,524 431,158 3.48%
  YoY % 0.75% 7.97% 3.15% -8.24% 22.00% -2.23% -
  Horiz. % 122.80% 121.89% 112.89% 109.45% 119.28% 97.77% 100.00%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 77,674 72,486 41,477 41,187 35,304 10,698 39,585 11.88%
  YoY % 7.16% 74.76% 0.71% 16.66% 230.00% -72.97% -
  Horiz. % 196.22% 183.11% 104.78% 104.05% 89.19% 27.03% 100.00%
Div Payout % 92.42 % 77.24 % 75.14 % 66.74 % 67.69 % 35.21 % 65.77 % 5.83%
  YoY % 19.65% 2.79% 12.59% -1.40% 92.25% -46.46% -
  Horiz. % 140.52% 117.44% 114.25% 101.47% 102.92% 53.54% 100.00%
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 529,482 525,526 486,754 471,886 514,273 421,524 431,158 3.48%
  YoY % 0.75% 7.97% 3.15% -8.24% 22.00% -2.23% -
  Horiz. % 122.80% 121.89% 112.89% 109.45% 119.28% 97.77% 100.00%
NOSH 258,915 258,880 258,911 117,677 117,682 106,985 106,987 15.86%
  YoY % 0.01% -0.01% 120.02% -0.00% 10.00% -0.00% -
  Horiz. % 242.01% 241.97% 242.00% 109.99% 110.00% 100.00% 100.00%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 3.86 % 4.44 % 2.92 % 3.49 % 3.47 % 2.20 % 4.75 % -3.40%
  YoY % -13.06% 52.05% -16.33% 0.58% 57.73% -53.68% -
  Horiz. % 81.26% 93.47% 61.47% 73.47% 73.05% 46.32% 100.00%
ROE 15.87 % 17.86 % 11.34 % 13.08 % 10.14 % 7.21 % 13.96 % 2.16%
  YoY % -11.14% 57.50% -13.30% 28.99% 40.64% -48.35% -
  Horiz. % 113.68% 127.94% 81.23% 93.70% 72.64% 51.65% 100.00%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 845.57 820.05 751.85 1,540.10 1,292.44 1,288.35 1,215.84 -5.87%
  YoY % 3.11% 9.07% -51.18% 19.16% 0.32% 5.96% -
  Horiz. % 69.55% 67.45% 61.84% 126.67% 106.30% 105.96% 100.00%
EPS 32.46 36.25 21.32 52.44 44.32 28.40 56.26 -8.75%
  YoY % -10.46% 70.03% -59.34% 18.32% 56.06% -49.52% -
  Horiz. % 57.70% 64.43% 37.90% 93.21% 78.78% 50.48% 100.00%
DPS 30.00 28.00 16.02 35.00 30.00 10.00 37.00 -3.43%
  YoY % 7.14% 74.78% -54.23% 16.67% 200.00% -72.97% -
  Horiz. % 81.08% 75.68% 43.30% 94.59% 81.08% 27.03% 100.00%
NAPS 2.0450 2.0300 1.8800 4.0100 4.3700 3.9400 4.0300 -10.69%
  YoY % 0.74% 7.98% -53.12% -8.24% 10.91% -2.23% -
  Horiz. % 50.74% 50.37% 46.65% 99.50% 108.44% 97.77% 100.00%
Adjusted Per Share Value based on latest NOSH - 1,309,126
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 167.23 162.16 148.70 138.44 116.18 105.29 99.36 9.06%
  YoY % 3.13% 9.05% 7.41% 19.16% 10.34% 5.97% -
  Horiz. % 168.31% 163.20% 149.66% 139.33% 116.93% 105.97% 100.00%
EPS 6.42 7.17 4.22 4.71 3.98 2.32 4.60 5.71%
  YoY % -10.46% 69.91% -10.40% 18.34% 71.55% -49.57% -
  Horiz. % 139.57% 155.87% 91.74% 102.39% 86.52% 50.43% 100.00%
DPS 5.93 5.54 3.17 3.15 2.70 0.82 3.02 11.90%
  YoY % 7.04% 74.76% 0.63% 16.67% 229.27% -72.85% -
  Horiz. % 196.36% 183.44% 104.97% 104.30% 89.40% 27.15% 100.00%
NAPS 0.4045 0.4014 0.3718 0.3605 0.3928 0.3220 0.3293 3.49%
  YoY % 0.77% 7.96% 3.13% -8.22% 21.99% -2.22% -
  Horiz. % 122.84% 121.89% 112.91% 109.47% 119.28% 97.78% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 6.3600 4.5800 4.4500 8.1000 5.3600 5.3100 4.0000 -
P/RPS 0.75 0.56 0.59 0.53 0.41 0.41 0.33 14.66%
  YoY % 33.93% -5.08% 11.32% 29.27% 0.00% 24.24% -
  Horiz. % 227.27% 169.70% 178.79% 160.61% 124.24% 124.24% 100.00%
P/EPS 19.59 12.63 20.87 15.45 12.09 18.70 7.11 18.39%
  YoY % 55.11% -39.48% 35.08% 27.79% -35.35% 163.01% -
  Horiz. % 275.53% 177.64% 293.53% 217.30% 170.04% 263.01% 100.00%
EY 5.10 7.91 4.79 6.47 8.27 5.35 14.07 -15.55%
  YoY % -35.52% 65.14% -25.97% -21.77% 54.58% -61.98% -
  Horiz. % 36.25% 56.22% 34.04% 45.98% 58.78% 38.02% 100.00%
DY 4.72 6.11 3.60 4.32 5.60 1.88 9.25 -10.60%
  YoY % -22.75% 69.72% -16.67% -22.86% 197.87% -79.68% -
  Horiz. % 51.03% 66.05% 38.92% 46.70% 60.54% 20.32% 100.00%
P/NAPS 3.11 2.26 2.37 2.02 1.23 1.35 0.99 21.01%
  YoY % 37.61% -4.64% 17.33% 64.23% -8.89% 36.36% -
  Horiz. % 314.14% 228.28% 239.39% 204.04% 124.24% 136.36% 100.00%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 15/02/16 23/02/15 24/02/14 18/02/13 22/02/12 25/02/11 19/02/10 -
Price 6.1900 5.2800 4.2900 7.8000 5.9000 5.3500 4.0500 -
P/RPS 0.73 0.64 0.57 0.51 0.46 0.42 0.33 14.14%
  YoY % 14.06% 12.28% 11.76% 10.87% 9.52% 27.27% -
  Horiz. % 221.21% 193.94% 172.73% 154.55% 139.39% 127.27% 100.00%
P/EPS 19.07 14.57 20.12 14.87 13.31 18.84 7.20 17.62%
  YoY % 30.89% -27.58% 35.31% 11.72% -29.35% 161.67% -
  Horiz. % 264.86% 202.36% 279.44% 206.53% 184.86% 261.67% 100.00%
EY 5.24 6.87 4.97 6.72 7.51 5.31 13.89 -14.99%
  YoY % -23.73% 38.23% -26.04% -10.52% 41.43% -61.77% -
  Horiz. % 37.72% 49.46% 35.78% 48.38% 54.07% 38.23% 100.00%
DY 4.85 5.30 3.73 4.49 5.08 1.87 9.14 -10.02%
  YoY % -8.49% 42.09% -16.93% -11.61% 171.66% -79.54% -
  Horiz. % 53.06% 57.99% 40.81% 49.12% 55.58% 20.46% 100.00%
P/NAPS 3.03 2.60 2.28 1.95 1.35 1.36 1.00 20.28%
  YoY % 16.54% 14.04% 16.92% 44.44% -0.74% 36.00% -
  Horiz. % 303.00% 260.00% 228.00% 195.00% 135.00% 136.00% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Health minister: Traveller from South Africa on Nov 19 is Malaysia’s first Omicron case save malaysia!
2. WHO urges Asia-Pacific to ready for Omicron-driven surge in infections Good Articles to Share
3. The case of ATA IMS: A tip of the iceberg? By Veeriah save malaysia!
4. 3QCY21 Results Review - Fat Tails Kenanga Research & Investment
5. Aurelius Technologies Bhd - Global EMS Provider PublicInvest Research
6. Strategy - A decent 3Q2021 but uncertainty has increased AmInvest Research Reports
7. MIDF Research maintains 'buy' recommendation on FGV, target price unchanged at RM2.20 (FANTASTIC: ALL PALM OIL STOCKS SHOULD RE RERATED, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
8. Latest Land Disposal in Sg Tiram, Johor, shows Palm Oil Companies with Huge Landbanks with Cheap Book Value are Jewels, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

362  474  546  892 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VSOLAR 0.015-0.005 
 VS 1.15-0.27 
 THHEAVY 0.015-0.05 
 VS-WB 0.355-0.09 
 IMPIANA 0.085+0.005 
 INARI 3.87-0.23 
 GOCEAN 0.0350.00 
 DNEX 0.745-0.025 
 ATAIMS 0.445+0.035 
 EAH 0.02+0.005 
PARTNERS & BROKERS